产品
编 号：F438855
分子式：C11H10N2O
分子量：186.21
分子式：C11H10N2O
分子量：186.21
产品类型
规格
价格
是否有货
结构图
CAS No: 72583-92-7
产品详情
生物活性：
RX 801077 (2 BFI free base) is a selective imidazoline I2 receptor (I2R) agonist with a Ki value of 70.1 nM. RX 801077 shows anti-inflammation and neuroprotection. RX 801077 has the potential for the research of traumatic brain injury (TBI).
体内研究：
RX 801077 (5、10、20 mg/kg；腹腔注射；每天两次，持续 3 天) 在创伤性脑损伤大鼠模型中抑制 NLRP3 炎性体诱导的炎症和坏死性凋亡。Animal Model:280-300 g, Male adult Sprague-Dawley rats (TBI model)
Dosage:5, 10, 20 mg/kg
Administration:I.p.; twice daily for 3 days
Result:Attenuated neurological deficits, brain edema, BBB permeability and cortical tissue loss in a rat model of TBI, reduced microglial activation, neutrophil infiltration, and proinflammatory cytokine IL-1β secretion, reduced the expression of RIP1 and RIP3 in neurons in the pericontusional cortex.
RX 801077 (2 BFI free base) is a selective imidazoline I2 receptor (I2R) agonist with a Ki value of 70.1 nM. RX 801077 shows anti-inflammation and neuroprotection. RX 801077 has the potential for the research of traumatic brain injury (TBI).
体内研究：
RX 801077 (5、10、20 mg/kg；腹腔注射；每天两次，持续 3 天) 在创伤性脑损伤大鼠模型中抑制 NLRP3 炎性体诱导的炎症和坏死性凋亡。Animal Model:280-300 g, Male adult Sprague-Dawley rats (TBI model)
Dosage:5, 10, 20 mg/kg
Administration:I.p.; twice daily for 3 days
Result:Attenuated neurological deficits, brain edema, BBB permeability and cortical tissue loss in a rat model of TBI, reduced microglial activation, neutrophil infiltration, and proinflammatory cytokine IL-1β secretion, reduced the expression of RIP1 and RIP3 in neurons in the pericontusional cortex.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备